Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.

Abstract

Using measurements of circulating anti-Müllerian hormone (AMH) in diagnosing and managing reproductive disorders in pediatric patients requires thorough knowledge on normative values according to age and gender. We provide age- and sex-specific reference ranges for the Immunotech assay and conversion factors for the DSL and Generation II assays. With this tool in hand, the pediatrician can use serum concentrations of AMH when determining the presence of testicular tissue in patients with bilaterally absent testes or more severe Disorders of Sex Development (DSD). Furthermore, AMH can be used as a marker of premature ovarian insufficiency (POI) in both Turner Syndrome patients and in girls with cancer after treatment with alkylating gonadotoxic agents. Lastly, its usefulness has been proposed in the diagnosis of polycystic ovarian syndrome (PCOS) and ovarian granulosa cell tumors and in the evaluation of patients with hypogonadotropic hypogonadism.

• Authors: Marie Lindhardt Johansen, Casper P Hagen, Trine Holm Johannsen, Katharina M Main, Jean-Yves Picard, Anne Jørgensen, Ewa Rajpert-De Meyts, Anders Juul
• Journal: International journal of endocrinology (Int J Endocrinol) Vol. 2013 Pg. 198698 ( 2013) ISSN: 1687-8337 [Print] Egypt
• PMID: 24367377 (Publication Type: Journal Article, Review)